does hap cover glp 1 GLP-1 Medications for Dialysis Patients in 2026 GLP-1 Injections for Medical Weight

During the COVID-era surge in demand for GLP-1 medications, Ozempic and Wegovy were both placed on the FDAs drug shortage list in 2022

doi:10.1371/journal.pone.0148871CrossRefGoogle ScholarPubMed McIntyre, RS

Knowing what to expect and how long it typically lasts can help you stay committed to your weight loss journey

Latin America held a 3% share of the market in 2025 and is expected to grow at a significant CAGR of 14% during the projection period, driven by GLP-1 medications that are driving structural health and economic shifts across Latin America by curbing surging obesity and type-2 diabetes rates, spurring vast biopharma investments, and fundamentally changing consumer habits in the fast-moving consumer goods sector

For example, by eating more slowly, you swallow less air that eventually gets burped out